| 2021 | | A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer | 허훈 |
| 2018 | | A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
| 2018 | | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance | 노오규, 오승엽, 오영택, 전미선, 조오연, 허재성 |
| 2016 | | Acantholytic squamous cell carcinoma of the oesophagus with prevalent single isolated tumour cells including signet ring cells and many osteoclast-like giant cells | 이다근 |
| 2019 | | ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data | 고영화, 정준호, 한재호, 함석진 |
| 2018 | | Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease | 김현아, 서창희, 정주양 |
| 2015 | | AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. | 왕희정 |
| 2016 | | Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party | 한재호 |
| 2018 | | Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma | 고영화, 이수진 |
| 2016 | | Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy | 김봉완, 왕희정 |
| 2015 | | BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma. | 김장희 |
| 2023 | | Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection | 우현구 |
| 2016 | | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer | 강석윤 |
| 2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2016 | | Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer | 백지흠 |
| 2017 | | Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer | 이다근, 허훈 |
| 2014 | | Colonic mucosa-associated lymphoid tissue lymphoma identified by chromoendoscopy | 강준구, 김광민, 김도완, 이득주, 이승화, 이정훈 |
| 2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
| 2020 | | Current Perspectives on (89)Zr-PET Imaging | 박복남, 안영실, 윤준기, 이수진 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
| 2021 | | Determinants of response and intrinsic resistance to pd-1 blockade in microsatellite instability–high gastric cancer | 김규태 |
| 2016 | | Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation | 김영환 |
| 2022 | | Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database | 김봉완 |
| 2018 | | Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer | 정용식 |
| 2021 | | Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer | 허훈 |
| 2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
| 2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
| 2017 | | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | 서광욱 |
| 2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
| 2015 | | Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. | 한재호 |
| 2018 | | ESE1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo | 김철호, 이복순 |
| 2020 | | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2014 | | Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma. | 강희영, 김유찬, 이은소, 한재호 |
| 2021 | | Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer | 고영화, 한재호, 함석진 |
| 2021 | | Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer | 노진 |
| 2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
| 2018 | | Gastrokine 1 protein is a potential theragnostic target for gastric cancer | 함인혜, 허훈 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2023 | | Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer | 안미선 |
| 2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2021 | | Identification and complete validation of prognostic gene signatures for human papillomavirus-associated cancers: Integrated approach covering different anatomical locations | 장전엽 |
| 2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
| 2023 | | Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma | 고영화, 박범희, 이현우, 한재호, 함석진 |
| 2016 | | Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma | 고영화, 이다근, 허훈 |
| 2024 | | Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types | 김석휘 |
| 2020 | | Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma | 손상용, 한상욱, 함인혜, 허훈 |
| 2018 | | Inhibition of TNFalpha-interacting protein alpha (Tipalpha)-associated gastric carcinogenesis by BTG2(/TIS21) via downregulating cytoplasmic nucleolin expression | 임인경 |
| 2015 | | Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression. | 고영화 |
| 2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
| 2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2015 | | Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. | 김영배, 이다근, 허훈 |
| 2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
| 2021 | | MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer | 김석휘, 배원정, 이다근 |
| 2021 | | MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness | 박태준, 우현구, 윤계순, 이영경 |
| 2024 | | Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | 이현우 |
| 2017 | | PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma | 고영화, 한재호 |
| 2019 | | Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers | 이진구 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2017 | | Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418) | 전미선 |
| 2017 | | Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients | 이다근, 허훈 |
